Effectively controlling the ESIPT behavior and fluorescence feature of 2-(2′-hydroxyphenyl)-4-chloromethylthiazole by changing its π-conjugation: A theoretical exploration

Influence of Solvents and Halogenation on ESIPT of Benzimidazole Derivatives for Designing Turn-on Fluorescence Probes

This work reports a theoretical investigation of the solvent polarity as well as the halogenation of benzimidazole derivatives during excited state intramolecular proton transfer (ESIPT). It details how the environment and halogen substitution may contribute to the efficiency of ESIPT upon keto-enol tautomerism and exploits this effect to design fluorescence sensing. For this purpose, we first examine the conformational equilibrium of benzimidazole derivatives containing different halogen atoms, which results in intramolecular proton transfer, using density-functional theory (DFT) combined with the polarizable continuum model (PCM). Then we evaluate the fluorescence of the benzimidazole derivatives in different dielectric constants within time-dependent DFT (TD-DFT) approaches. Our results quantitatively allow the determination of large Stokes shifts in nonpolar solvents around 100 nm. These theoretical results are in agreement with experimental solvatochromism studies of benzimidazoles. The effect of halogenation, with fluorine, chlorine, and bromine, is less important than solvent polarization when ESIPT takes place. Thus, halogenation can be properly chosen depending on the interest of the synthesis of benzimidazole-based turn-on fluorescence in appropriate solvents.

ESIPT-Capable 4-(2-Hydroxyphenyl)-2-(Pyridin-2-yl)-1H-Imidazoles with Single and Double Proton Transfer: Synthesis, Selective Reduction of the Imidazolic OH Group and Luminescence

1H-Imidazole derivatives establish one of the iconic classes of ESIPT-capable compounds (ESIPT = excited state intramolecular proton transfer). This work presents the synthesis of 1-hydroxy-4-(2-hydroxyphenyl)-5-methyl-2-(pyridin-2-yl)-1H-imidazole (L^OH,OH) as the first example of ESIPT-capable imidazole derivatives wherein the imidazole moiety simultaneously acts as a proton acceptor and a proton donor. The reaction of L^OH,OH with chloroacetone leads to the selective reduction of the imidazolic OH group (whereas the phenolic OH group remains unaffected) and to the isolation of 4-(2-hydroxyphenyl)-5-methyl-2-(pyridin-2-yl)-1H-imidazole (L^H,OH), a monohydroxy congener of L^OH,OH. Both L^OH,OH and L^H,OH demonstrate luminescence in the solid state. The number of OH···N proton transfer sites in these compounds (one for L^H,OH and two for L^OH,OH) strongly affects the luminescence mechanism and color of the emission: L^H,OH emits in the light green region, whereas L^OH,OH luminesces in the orange region. According to joint experimental and theoretical studies, the main emission pathway of both compounds is associated with T₁ → S₀ phosphorescence and not related to ESIPT. At the same time, L^OH,OH also exhibits S₁ → S₀ fluorescence associated with ESIPT with one proton transferred from the hydroxyimidazole moiety to the pyridine moiety, which is not possible for L^H,OH due to the absence of the hydroxy group in the imidazole moiety.

Tuning ESIPT-coupled luminescence by expanding π-conjugation of a proton acceptor moiety in ESIPT-capable zinc(II) complexes with 1-hydroxy-1H-imidazole-based ligands

The emission of ESIPT-fluorophores is known to be sensitive to various external and internal stimuli and can be fine-tuned through substitution in the proton-donating and proton-accepting groups. The incorporation of metal ions in the molecules of ESIPT fluorophores without their deprotonation is an emerging area of research in coordination chemistry which provides chemists with a new factor affecting the ESIPT reaction and ESIPT-coupled luminescence. In this paper we present 1-hydroxy-5-methyl-4-(pyridin-2-yl)-2-(quinolin-2-yl)-1H-imidazole (HLq) as a new ESIPT-capable ligand. Due to the spatial separation of metal binding and ESIPT sites this ligand can coordinate metal ions without being deprotonated. The reactions of ZnHal₂ with HLq afford ESIPT-capable [Zn(HLq)Hal2] (Hal = Cl, Br, I) complexes. In the solid state HLq and [Zn(HLq)Hal2] luminesce in the orange region (λ_max = 600-650 nm). The coordination of HLq by Zn²⁺ ions leads to the increase in the photoluminescence quantum yield due to the chelation-enhanced fluorescence effect. The ESIPT process is barrierless in the S₁ state, leading to the only possible fluorescence channel in the tautomeric form (T), S₁^T → S₀^T. The emission of [Zn(HLq)Hal2] in the solid state is blue-shifted as compared with HLq due to the stabilization of the ground state and destabilization of the excited state. In CH₂Cl₂ solutions, the compounds demonstrate dual emission in the UV (λ_max = 358 nm) and green (λ_max = 530 nm) regions. This dual emission is associated with two radiative deactivation channels in the normal (N) and tautomeric (T) forms, S₁^N → S₀^N and S₁^T → S₀^T, originating from two minima on the excited state potential energy surfaces. High energy barriers for the GSIPT process allow the trapping of molecules in the minimum of the tautomeric form, S₀^T, resulting in the possibility of the S₀^T → S₁^T photoexcitation and extraordinarily small Stokes shifts in the solid state. Finally, the π-system of quinolin-2-yl group facilitates the delocalization of the positive charge in the proton-accepting part of the molecule and promotes the ESIPT reaction.